Experience with the systemic treatment of severe forms of psoriasis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F12%3A33138512" target="_blank" >RIV/61989592:15110/12:33138512 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.5507/bp.2012.007" target="_blank" >http://dx.doi.org/10.5507/bp.2012.007</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5507/bp.2012.007" target="_blank" >10.5507/bp.2012.007</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Experience with the systemic treatment of severe forms of psoriasis

Popis výsledku v původním jazyce

Introduction: Severe forms of psoriasis, where traditional topical therapy fails, are indicated for systemic treatment with conventional and biological medicinal products. The conventional systemic therapy includes phototherapy and treatment with methotrexate, cyclosporin and acitretin. Currently used biological preparations include inhibitors of TNF-alpha (etanercept, adalimumab, infliximab) and monoclonal antibody ustekinumab. We are presenting our own more than five-year experience with systemic treatment of severe forms of psoriasis. Methods: A total of 66 patients treated with systemic therapy (except for phototherapy) were divided into groups based on provided therapy. Therapeutic doses were administered according to the recommendations of the manufacturer and dermatological societies. Standard PASI and BSA indices were used to evaluate clinical condition at weeks 0, 12 and 24. Collected data were statistically evaluated using SPSS software version 15 (SPSS Inc.; Chicago, USA) at

Název v anglickém jazyce

Experience with the systemic treatment of severe forms of psoriasis

Popis výsledku anglicky

Introduction: Severe forms of psoriasis, where traditional topical therapy fails, are indicated for systemic treatment with conventional and biological medicinal products. The conventional systemic therapy includes phototherapy and treatment with methotrexate, cyclosporin and acitretin. Currently used biological preparations include inhibitors of TNF-alpha (etanercept, adalimumab, infliximab) and monoclonal antibody ustekinumab. We are presenting our own more than five-year experience with systemic treatment of severe forms of psoriasis. Methods: A total of 66 patients treated with systemic therapy (except for phototherapy) were divided into groups based on provided therapy. Therapeutic doses were administered according to the recommendations of the manufacturer and dermatological societies. Standard PASI and BSA indices were used to evaluate clinical condition at weeks 0, 12 and 24. Collected data were statistically evaluated using SPSS software version 15 (SPSS Inc.; Chicago, USA) at

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FO - Dermatovenerologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Biomedical Papers-Olomouc

ISSN

1213-8118

e-ISSN

—

Svazek periodika

156

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

12

Strana od-do

29-40

Kód UT WoS článku

000302753000005

EID výsledku v databázi Scopus

—